Clinical Trial Update: Safety and Pharmacokinetics of Recombinant Factor XIII in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety and pharmacokinetics of recombinant Factor XIII in healthy volunteers. The results summarize tolerability and the pharmacokinetic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Factor Xiii Deficiency

Drugs mentioned

• Recombinant Factor XIII (Factor XIII, recombinant)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Congenital FXIII Deficiency | Phase 1 | Status: COMPLETED